ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,475Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 16

$549K Total Retail Price of All Prescriptions

Rank: 7 out of 16

925 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

26% of this provider’s 925 patients filled at least one prescription for a schedule two drug, compared to an average of 17%.

Schedule Three
Controlled Substances

9% of this provider’s 925 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 8,594 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 469 455 1 1
LISINOPRIL 442 426 2 3
FUROSEMIDE 290 280 3 4
OMEPRAZOLE 283 270 4 8
HYDROCODONE-ACETAMINOPHEN 265 234 S3 5 5
SIMVASTATIN 257 249 6 6
METOPROLOL TARTRATE 244 236 7 10
AMLODIPINE BESYLATE 176 157 8 12
OXYCODONE-ACETAMINOPHEN 171 102 S2 9 42
OXYCODONE HCL 169 118 S2 10 29
GABAPENTIN 144 124 11 9
CITALOPRAM HBR 143 134 12 7
FENTANYL 142 105 S2 13 31
ZOLPIDEM TARTRATE 127 101 14 64
METFORMIN HCL 127 125 14 18
WARFARIN SODIUM 125 116 16 2
METOPROLOL SUCCINATE 121 120 17 21
MORPHINE SULFATE ER 118 71 S2 18 54
NAMENDA 109 105 19 15
LOSARTAN POTASSIUM 104 91 20 39
ATENOLOL 99 99 21 38
ESCITALOPRAM OXALATE 97 94 22 25
DONEPEZIL HCL 96 96 23 11
TRAMADOL HCL 92 92 24 17
TAMSULOSIN HCL 90 73 25 22
GALANTAMINE HBR 85 85 26 120
SERTRALINE HCL 83 83 27 16
HYDROCHLOROTHIAZIDE 83 80 27 30
POTASSIUM CHLORIDE 80 76 29 13
ATORVASTATIN CALCIUM 77 73 30 41
LIDOCAINE 76 76 31 142
OXYCONTIN 75 50 S2 32 63
LOVASTATIN 75 71 32 102
MIRTAZAPINE 70 64 34 14
PANTOPRAZOLE SODIUM 70 63 34 46
QUETIAPINE FUMARATE 69 65 36 19
CELEBREX 68 68 37 126
LYRICA 67 57 38 98
ALENDRONATE SODIUM 65 53 39 47
RANITIDINE HCL 64 59 40 52
ISOSORBIDE MONONITRATE ER 60 57 41 77
GLIPIZIDE 59 55 42 69
DIGOXIN 59 57 42 53
ALLOPURINOL 56 45 44 48
LIDODERM 53 47 45 27
PREDNISONE 52 41 46 36
KLOR-CON M20 52 49 46 34
CYCLOBENZAPRINE HCL 51 43 R 48 135
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.